Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E A Stadtmauer

Showing results (21-30 of 60) with videos related to

Pageof 6
Sort By:
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|March 16, 2011
Association of HLA polymorphisms with post-transplant lymphoproliferative disorder in solid-organ transplant recipientsR Reshef, M R Luskin, M Kamoun, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 14, 2002
Alemtuzumab in previously treated chronic lymphocytic leukemia patients who also had received fludarabineK R Rai, C E Freter, R J Mercier, et al.
Cytotherapy|May 25, 2002
Tumor cell depletion of peripheral blood progenitor cells using positive and positive/negative selection in metastatic breast cancerR A Preti, H M Lazarus, J Winter, et al.
Annals of Hematology|August 20, 2002
Nonmyeloablative allogeneic stem cell transplantation for refractory Hodgkin's lymphoma complicated by interleukin-2 responsive progressive multifocal leukoencephalopathyR J Buckanovich, G Liu, C Stricker, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 18, 2000
Phase I trial of TALL-104 cells in patients with refractory metastatic breast cancerS Visonneau, A Cesano, D L Porter, et al.
Leukemia|November 11, 2006
Bortezomib appears to overcome the poor prognosis conferred by chromosome 13 deletion in phase 2 and 3 trialsS Jagannath, P G Richardson, P Sonneveld, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1993
Autologous bone marrow transplant in acute myeloid leukemia in first remissionP A Cassileth, J Andersen, H M Lazarus, et al.
Bone Marrow Transplantation|September 11, 2001
Effect of induction chemotherapy and tandem cycles of high-dose chemotherapy on outcomes in autologous stem cell transplant for metastatic breast cancerA L Pecora, H M Lazarus, E A Stadtmauer, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 27, 1999
Economic analysis of a randomized placebo-controlled phase III study of granulocyte macrophage colony stimulating factor in adult patients (> 55 to 70 years of age) with acute myelogenous leukemia. Eastern Cooperative Oncology Group (E1490)C L Bennett, T J Stinson, M S Tallman, et al.
Bone Marrow Transplantation|July 10, 2002
Gemtuzumab ozogamicin (Mylotarg) monotherapy for relapsed AML after hematopoietic stem cell transplant: efficacy and incidence of hepatic veno-occlusive diseaseA D Cohen, S M Luger, C Sickles, et al.
Pageof 6

Showing results (21-30 of 60) with videos related to

Sort By:
Pageof 6
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|March 16, 2011
Association of HLA polymorphisms with post-transplant lymphoproliferative disorder in solid-organ transplant recipientsR Reshef, M R Luskin, M Kamoun, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 14, 2002
Alemtuzumab in previously treated chronic lymphocytic leukemia patients who also had received fludarabineK R Rai, C E Freter, R J Mercier, et al.
Cytotherapy|May 25, 2002
Tumor cell depletion of peripheral blood progenitor cells using positive and positive/negative selection in metastatic breast cancerR A Preti, H M Lazarus, J Winter, et al.
Annals of Hematology|August 20, 2002
Nonmyeloablative allogeneic stem cell transplantation for refractory Hodgkin's lymphoma complicated by interleukin-2 responsive progressive multifocal leukoencephalopathyR J Buckanovich, G Liu, C Stricker, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 18, 2000
Phase I trial of TALL-104 cells in patients with refractory metastatic breast cancerS Visonneau, A Cesano, D L Porter, et al.
Leukemia|November 11, 2006
Bortezomib appears to overcome the poor prognosis conferred by chromosome 13 deletion in phase 2 and 3 trialsS Jagannath, P G Richardson, P Sonneveld, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1993
Autologous bone marrow transplant in acute myeloid leukemia in first remissionP A Cassileth, J Andersen, H M Lazarus, et al.
Bone Marrow Transplantation|September 11, 2001
Effect of induction chemotherapy and tandem cycles of high-dose chemotherapy on outcomes in autologous stem cell transplant for metastatic breast cancerA L Pecora, H M Lazarus, E A Stadtmauer, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 27, 1999
Economic analysis of a randomized placebo-controlled phase III study of granulocyte macrophage colony stimulating factor in adult patients (> 55 to 70 years of age) with acute myelogenous leukemia. Eastern Cooperative Oncology Group (E1490)C L Bennett, T J Stinson, M S Tallman, et al.
Bone Marrow Transplantation|July 10, 2002
Gemtuzumab ozogamicin (Mylotarg) monotherapy for relapsed AML after hematopoietic stem cell transplant: efficacy and incidence of hepatic veno-occlusive diseaseA D Cohen, S M Luger, C Sickles, et al.
Pageof 6